On March 5, 2025, Lumata Health, a leader in personalized support for patients with vision-threatening chronic eye diseases, announced that it has raised $23 million in Series B funding to accelerate its mission of eliminating preventable vision loss, bringing its total raised since inception to $36 million. The round was co-led by LRVHealth, McKesson Ventures, and Cencora Ventures, with participation from existing investors, including Cortado Ventures. The investment will enable Lumata to meet growing demand and further enhance the data-driven technology powering its patient adherence solutions.

Wilson Sonsini Goodrich & Rosati represented Lumata in the transaction. The Wilson Sonsini team included Brian Dillavou, Lucas Sheets, Varun Lella, and Margaret LaMore.

For more information, please see the company’s news release.